X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Orchid Chemicals Fact Sheet, Orchid Chemicals Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Fact Sheet   (ORCHID)

Here is the latest financial fact sheet of Orchid Chemicals. For more details, see the Orchid Chemicals quarterly results and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA LTD Price History

Price Rs 7.3
Mkt Cap Rs m 620
Vol '000 35.2
P/E X 0.1
P/CF X -0.2
EPS (TTM) Rs 52.8
% ch % 0.1
No. of shares m 85.26
% ch week % -9.5
% ch 1-mth % -37.1
% ch 12-mth % -75.5
52 week H/L Rs 32.0/6.8
(As on May 23, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA LTD Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
18
Sep-13
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA LTD EQUITY SHARE DATA
High Rs330239344325194 
Low Rs577512811235 
Sales per share (Unadj.) Rs184.1190.7253.0266.0276.5 
Earnings per share (Unadj.) Rs-7.048.222.213.8-79.2 
Diluted earnings per shareRs-5.739.818.311.4-65.5 
Cash flow per share (Unadj.) Rs12.170.241.135.7-43.5 
Dividends per share (Unadj.) Rs1.0010.003.003.000 
Adj. dividends per shareRs0.838.262.482.480.00 
Dividend yield (eoy) %0.56.41.31.40 
Book value per share (Unadj.) Rs90.0133.1151.8160.753.9 
Adj. book value per shareRs74.3110.0125.4132.844.6 
Shares outstanding (eoy) m70.4470.4470.4470.4470.45 
Bonus/Rights/Conversions  WC---ESOP 
Price / Sales ratio x1.10.80.90.80.4 
Avg P/E ratio x-27.83.310.615.8-1.4 
P/CF ratio (eoy) x16.02.25.76.1-2.6 
Price / Book Value ratio x2.21.21.61.42.1 
Dividend payout %-14.420.813.521.70 
Avg Mkt Cap Rs m13,63011,05916,62415,3918,067 
No. of employees `0004.03.7NA4.52.8 
Total wages/salary Rs m1,4091,7751,7371,7642,527 
Avg. sales/employee Rs Th3,210.03,630.9NM4,205.66,956.1 
Avg. wages/employee Rs Th348.7479.8NM396.0902.5 
Avg. net profit/employee Rs Th-121.3916.9NM218.8-1,993.0 
ORCHID PHARMA LTD INCOME DATA
Net Sales Rs m12,96913,43517,81818,73619,477 
Other income Rs m86186447562407 
Total revenues Rs m13,82913,52018,26519,29819,884 
Gross profit Rs m1,706-1,5693,5643,5661,103 
Depreciation Rs m1,3401,5491,3351,5372,519 
Interest Rs m1,5652,4231,1681,7985,227 
Profit before tax Rs m-338-5,4551,509793-6,236 
Minority Interest Rs m000020 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m010,153207-39511 
Tax Rs m1521,306154-220-125 
Profit after tax Rs m-4903,3931,562975-5,580 
Gross profit margin %13.2-11.720.019.05.7 
Effective tax rate %-44.9-23.910.2-27.82.0 
Net profit margin %-3.825.38.85.2-28.7 
ORCHID PHARMA LTD BALANCE SHEET DATA
Current assets Rs m15,95417,00515,26312,53311,014 
Current liabilities Rs m8,55810,85219,89415,51132,060 
Net working cap to sales %57.045.8-26.0-15.9-108.1 
Current ratio x1.91.60.80.80.3 
Inventory Days Days21611512713095 
Debtors Days Days1892001052234 
Net fixed assets Rs m25,54220,72220,74124,26129,440 
Share capital Rs m704704704704705 
"Free" reserves Rs m5,4798,4548,1069,3102,043 
Net worth Rs m6,3389,37710,69211,3233,800 
Long term debt Rs m26,15915,3036,04110,7429,018 
Total assets Rs m43,91639,90639,10239,38146,510 
Interest coverage x0.8-1.32.31.4-0.2 
Debt to equity ratio x4.11.60.60.92.4 
Sales to assets ratio x0.30.30.50.50.4 
Return on assets %2.414.67.07.0-0.8 
Return on equity %-7.736.214.68.6-146.9 
Return on capital %3.828.917.211.6-3.7 
Exports to sales %71.972.740.745.237.9 
Imports to sales %32.728.232.437.822.6 
Exports (fob) Rs m9,3209,7627,2598,4677,378 
Imports (cif) Rs m4,2343,7875,7737,0894,406 
Fx inflow Rs m9,59210,0527,8688,9287,513 
Fx outflow Rs m5,0065,2676,6588,2195,649 
Net fx Rs m4,5864,7851,2107091,865 
ORCHID PHARMA LTD CASH FLOW
From Operations Rs m 459 -343 3,321 7,370 1,682 
From Investments Rs m -4,770 14,128 -3,674 -2,931 -9,860 
From Financial Activity Rs m 4,311 -10,768 -778 -4,802 6,644 
Net Cashflow Rs m 0 3,016 -1,130 -362 -1,535 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 32.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 3.3%
ADR/GDR 4.6%
Free float 55.3%
Shareholders 84,811
Pledged promoter(s) holding 54.9%
 

Company Information

REGD OFF Orchid Towers, 313, Valluvar Kottam Road, Nungambakkam, Chennai-34
E-MAIL corporate@orchidpharma.com WEB www.orchidpharma.com
TELEPHONE (044) 2821 1000 FAX (044) 2827 5960
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterp., II Flr., Kences Tower, North Usman Rd., Chennai-17
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  PLETHICO PHARMA  IPCA LABS  PANACEA BIOTECH  GSK PHARMA  

Compare ORCHID PHARMA LTD With:   SUN PHARMA  PLETHICO PHARMA  IPCA LABS  PANACEA BIOTECH  GSK PHARMA  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Depreciating Rupee, Rising Fuel Prices, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. Sectoral indices traded on a mixed note, with stocks in the metal sector and stocks in the oil and gas sector, leading the losses.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS